Navigation Links
Elsevier launches new open access journal in biomedicine
Date:9/12/2013

New York, September 12, 2013 Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of a new open access research publication Journal of Clinical and Translational Endocrinology (JCTE).

The scope of this new journal is patient-oriented research in a variety of disciplines in endocrinology, including diabetes, metabolic bone disease and osteoporosis, thyroid disease, pituitary and lipid disorders. Areas of high priority include novel pilot/proof-of-concept clinical trials in humans and basic science research involving human specimens.

Dr. Vin Tangpricha from Emory University, Atlanta, Editor-in-Chief of the journal, said, "Journal of Clinical and Translational Endocrinology will provide authors a unique home for manuscripts focused on patient-oriented endocrinology research that translates basic science research to clinical applications for patients with endocrine diseases. As a practicing clinician and a researcher in endocrinology, I understand the importance of strengthening the relationship between the clinical and basic sciences. We look forward to providing the scientific community with high-yield content that addresses the needs of readers and investigators interested in translational research of endocrine diseases."

Andrew Miller, Executive Publisher at Elsevier, added, "Journal of Clinical and Translational Endocrinology will offer the research community a unique and dynamic blend of tradition and innovation: editorial review from an expert team of researchers together with our publishing and dissemination systems, involving innovative, digital approaches. Elsevier is very pleased to launch JCTE and work with Dr. Tangpricha and the journal editors to serve the needs of endocrinologists internationally."


'/>"/>

Contact: Brant Emery
b.emery@elsevier.com
31-020-485-3310
Elsevier
Source:Eurekalert

Page: 1

Related biology news :

1. Elsevier announces the launch of a new open access journal: Water Resources and Industry
2. Elsevier launches first video journal in gastrointestinal endoscopy
3. Elsevier launches open access journal: GeoResJ
4. Elsevier launches new open access journal: Translational Proteomics
5. Elseviers Maturitas publishes clinical guide on endometrial assessment in postmenopausal women
6. Elsevier announces the launch of a new journal: Wound Medicine
7. Elsevier announces the launch of a new journal: Methods in Oceanography
8. Elsevier wins 6 PROSE Awards
9. Elsevier announces the launch of a new journal: Journal of Forensic Radiology and Imaging
10. Elsevier announces the launch of a new journal: Anthropocene
11. Elsevier launches new open access journal: Molecular Metabolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/9/2017)... -- The biomass boiler market report by Transparency Market ... globally in terms of revenue (US$ Mn) based on ... biomass boilers has been segmented on the basis of ... market based on feedstock type, has been segmented into ... crops, urban residues, and others. On the basis of ...
(Date:2/8/2017)... 7, 2017 Report Highlights ... The global synthetic-biology market reached ... by 2021, growing at a compound annual growth rate (CAGR) ... of the global markets for synthetic biology. - Analyses of ... and projections of compound annual growth rates (CAGRs) through 2021. ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers ... from small lab samples to full-size tissues, bones, even whole organs to implant ... system that delivers blood deep into the developing tissue. , Current bioengineering ...
(Date:3/22/2017)... , March 22, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage ... drug delivery systems, announced today that Dr. ... deliver a presentation titled, "Oral Insulin for Diabetes ... Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference ...
(Date:3/22/2017)... /PRNewswire/ - FACIT announced a seed stage investment ... start-up created by FACIT focused on developing a ... with non-dilutive capital, achieves a targeted $3.0M financing ... Propellon to accelerate the nomination of a candidate ... entering a strategic partnership for clinical trials in ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, ... their live events series, “Stem Cell Therapy: The Next Phase in the Evolution of ... Stem Cell Research and Therapy Act, Okyanos maintains a mission to help ...
Breaking Biology Technology: